The Dime

The 2018 Farm Bill has undeniably reshaped the cannabis industry, blurring lines and unlocking opportunities between hemp and cannabis. This episode delves into the nuanced differences and similarities between these two facets of the cannabis world. Chris Fontes shares his insights to dissect the complex web of legislation, the evolving roles of MSOs and Big Pharma, and the boundless opportunities emerging from regulatory challenges. Discover how today's cannabis entrepreneurs are utilizing the

Major industry behemoths like P&G or British Tobacco are setting their sights on the cannabis industry, poised to disrupt and seamlessly integrate.In this rapidly evolving landscape, are you engaging in crucial internal and external conversations in anticipation of the next wave?This week, we sit down with Seth Yakatan to discuss the following:Founders and Companies set up for major exits.Secrets to a Profitable, Cash-Flowing OperationBuild to Sell vs Build to CompeteHow CPG giants are eyeing

Amidst the breaking down the walls of prohibition, it's clear that change is underway. The speed at which the cannabis industry is evolving is hard to truly grasp unless you step back and appreciate how much has altered in the last 10 years compared to the previous 100.While issues and unknowns persist, incremental progress with accelerated catalysts is gaining momentum, making one thing extremely clear:The genie is unlikely to go back into the bottle.This week, we sit down to reflect on the past

"Great companies were never built by conservative leaders.Great companies were built by risk-takers."Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities.Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.The US